Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Emerging drugs for the treatment of anxiety

Open access
Murrough, James W, Yaqubi, Sahab, Sayed, Sehrish, Charney, Dennis S·2015·Expert Opinion on Emerging Drugs

Abstract

INTRODUCTION: Anxiety disorders are among the most prevalent and disabling psychiatric disorders in the United States and worldwide. Basic research has provided critical insights into the mechanism regulating fear behavior in animals and a host of animal models have been developed in order to screen compounds for anxiolytic properties. Despite this progress, no mechanistically novel agents for the treatment of anxiety have come to market in more than two decades. AREAS COVERED: The current review will provide a critical summary of current pharmacological approaches to the treatment of anxiety and will examine the pharmacotherapeutic pipeline for treatments in development. Anxiety and related disorders considered herein include panic disorder, social anxiety disorder, generalized anxiety disorder and post-traumatic stress disorder. The glutamate, neuropeptide and endocannabinoid systems show particular promise as future targets for novel drug development. EXPERT OPINION: In the face of an ever-growing understanding of fear-related behavior, the field awaits the translation of this research into mechanistically novel treatments. Obstacles will be overcome through close collaboration between basic and clinical researchers with the goal of aligning valid endophenotypes of human anxiety disorders with improved animal models. Novel approaches are needed to move basic discoveries into new, more effective treatments for our patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/14728214.2015.1049996

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 99

  1. Schaffer A, 2012, Ann Clin Psychiatry., 24, 6
  2. 10.1002/da.22214 · DOI
  3. 10.1038/nrd4075 · DOI · Paper page
  4. 10.1080/j.1440-1614.2005.01510.x · DOI
  5. Watanabe N, 2009, Cochrane Database Syst Rev., 1, D005335
  6. Imai H, 2014, Cochrane Database Syst Rev., 9, D010828
  7. Stein DJ, 2006, Cochrane Database Syst Rev., 1, D002795
  8. Kapczinski F, 2003, Cochrane Database Syst Rev., 2, D003592
  9. 10.1017/S1461145710001434 · DOI · Paper page
  10. 10.1176/appi.ajp.158.12.1989 · DOI · Paper page
  11. 10.1001/archpsyc.58.7.681 · DOI
  12. 10.1002/wps.20087 · DOI · Paper page
  13. 10.1016/j.janxdis.2012.10.006 · DOI
  14. 10.1001/jamapsychiatry.2014.2470 · DOI
  15. 10.1007/s40265-013-0161-9 · DOI
  16. 10.1016/j.euroneuro.2012.07.012 · DOI
  17. 10.1016/j.euroneuro.2012.07.011 · DOI
  18. 10.1002/hup.2371 · DOI
  19. 10.1097/YIC.0b013e3283530ad7 · DOI
  20. 10.1517/17460441.2013.855195 · DOI
  21. Pierz KA, 2014, Prim Care Companion CNS Disord., 16, 10
  22. 10.1097/YIC.0000000000000045 · DOI
  23. 10.1016/j.euroneuro.2012.06.016 · DOI
  24. 10.1038/npp.2009.72 · DOI · Paper page
  25. 10.1097/JCP.0b013e318184ff5b · DOI · Paper page
  26. 10.1002/hup.2294 · DOI · Paper page
  27. De Berardis D, 2013, Int J Immunopathol Pharmacol., 26, 299, 10.1177/039463201302600203 · DOI
  28. 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J · DOI · Paper page
  29. 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.0.CO;2-I · DOI
  30. 10.1016/j.ynstr.2014.10.002 · DOI · Paper page
  31. 10.1176/appi.ajp.158.8.1227 · DOI · Paper page
  32. 10.1002/da.20292 · DOI · Paper page
  33. 10.1517/14656566.2014.930437 · DOI
  34. 10.1176/appi.ajp.163.12.2186 · DOI
  35. Davis LL, 2008, Psychopharmacol Bull., 41, 8
  36. 10.1111/acer.12520 · doi:10.1111/acer.12520
  37. 10.1016/j.jad.2004.11.007 · DOI
  38. 10.1590/S1516-44462008000400011 · DOI
  39. 10.1097/JCP.0b013e318224864d · DOI
  40. 10.1097/YIC.0b013e32834d9f49 · DOI
  41. 10.4088/JCP.v66n1016 · DOI
  42. Pandina GJ, 2007, Psychopharmacol Bull., 40, 41
  43. 10.1001/jama.2011.1080 · DOI · Paper page
  44. 10.1016/j.clinthera.2007.01.013 · DOI · Paper page
  45. 10.1001/archpsyc.62.9.1022 · DOI · Paper page
  46. 10.1097/YIC.0b013e32831d7980 · DOI
  47. 10.1136/bmj.d1199 · DOI · Paper page
  48. 10.1176/appi.ajp.160.3.533 · DOI · Paper page
  49. 10.1097/YIC.0b013e3283466657 · DOI
  50. 10.1097/01.pra.0000456590.12998.41 · DOI
  51. 10.1111/epi.12101 · DOI
  52. Lapidus KA, 2013, Neuropsychiatr Dis Treat., 9, 1101
  53. 10.1001/jamapsychiatry.2014.62 · DOI · Paper page
  54. 10.1016/j.biopsych.2012.05.028 · DOI · Paper page
  55. 10.1038/npp.2013.150 · DOI · Paper page
  56. 10.1517/13543784.2013.803066 · DOI
  57. 10.1038/sj.npp.1301531 · DOI · Paper page
  58. 10.1097/00004850-200511000-00001 · DOI
  59. 10.1111/bph.12779 · DOI
  60. 10.1016/j.biopsych.2009.07.036 · DOI · Paper page
  61. Chalmers DT, 1995, J Neurosci., 15, 6340, 10.1523/JNEUROSCI.15-10-06340.1995 · DOI · Paper page
  62. 10.1146/annurev.pharmtox.44.101802.121410 · DOI · Paper page
  63. 10.1016/S0022-3956(98)90056-5 · DOI · Paper page
  64. 10.1007/BF02244208 · DOI · Paper page
  65. 10.1016/0018-506X(87)90044-4 · DOI · Paper page
  66. 10.1016/j.ejphar.2004.12.030 · DOI
  67. Baker DG, 1999, Am J Psychiatry., 156, 585, 10.1176/ajp.156.4.585 · DOI · Paper page
  68. 10.1016/j.ejphar.2007.12.032 · DOI · Paper page
  69. 10.1002/da.20695 · DOI · Paper page
  70. 10.1016/j.bmcl.2010.10.095 · DOI
  71. 10.1002/emmm.201000100 · DOI · Paper page
  72. 10.1517/14728222.2011.628314 · DOI · Paper page
  73. 10.1016/j.biopsych.2014.01.009 · DOI
  74. 10.1016/j.biopsych.2013.11.012 · DOI
  75. 10.1016/j.npep.2004.05.002 · DOI · Paper page
  76. 10.1016/j.neuroscience.2013.01.040 · DOI · Paper page
  77. 10.1016/S0006-3223(99)00185-7 · DOI · Paper page
  78. 10.1016/j.biopsych.2005.08.027 · DOI · Paper page
  79. 10.1016/j.biopsych.2009.04.037 · DOI
  80. 10.1016/j.psyneuen.2013.10.017 · DOI
  81. 10.1126/science.281.5383.1640 · DOI · Paper page
  82. 10.1038/npp.2008.176 · DOI
  83. 10.1007/s11307-005-7001-6 · DOI
  84. 10.2165/00023210-200519040-00001 · DOI
  85. 10.1007/s00726-006-0335-9 · DOI · Paper page
  86. 10.1176/appi.ajp.163.4.637 · DOI
  87. 10.1016/j.euroneuro.2010.11.012 · DOI
  88. 10.1016/j.euroneuro.2009.10.005 · DOI
  89. 10.1016/j.neubiorev.2005.05.008 · DOI
  90. 10.1001/archpsyc.1989.01810060031006 · DOI · Paper page
  91. 10.1038/npp.2008.97 · DOI
  92. 10.1016/j.bbi.2014.06.007 · DOI
  93. 10.1016/0166-2236(90)90124-S · DOI · Paper page
  94. 10.3389/fnbeh.2011.00063 · DOI
  95. 10.1007/s40261-014-0212-3 · DOI · Paper page
  96. 10.1002/hup.1048 · DOI · Paper page
  97. 10.1590/S1516-44462009000200012 · DOI · Paper page
  98. 10.1016/j.pharmthera.2012.12.002 · DOI · Paper page
  99. 10.1016/j.tins.2011.06.007 · DOI · Paper page

Cited by

See all 164

Metadata

Authors
Murrough, J. W., Yaqubi, S., Sayed, S., & Charney, D. S.
Venue
Expert Opinion on Emerging Drugs
Published
2015-05-26
Volume
20
Issue
3
Pages
393-406
ISSN
  • 1472-8214 (ISSN-L)
  • 1744-7623
OpenAlex
W1744121855
Cited by
164
References
32
FWCI
11.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging drugs for the treatment of anxiety. https://app.cochat.ai/papers/10.1517/14728214.2015.1049996
The paper
Murrough, J. W., Yaqubi, S., Sayed, S., & Charney, D. S. (2015). Emerging drugs for the treatment of anxiety. Expert Opinion on Emerging Drugs. https://doi.org/10.1517/14728214.2015.1049996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.